These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17063878

  • 1. [Requirement of standardizing anti-HBs assay methods in Japan for HBV infection-preventing strategy--discrepancy of anti-HBs measurements among three different kits widely used in Japan].
    Ogata N.
    Rinsho Byori; 2006 Sep; 54(9):960-5. PubMed ID: 17063878
    [Abstract] [Full Text] [Related]

  • 2. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N.
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of antibody responses to hepatitis B surface antigen among four recipient groups of hepatitis B vaccines that have been approved in Japan: evaluation using passive hemagglutination assay and chemiluminescent immunoassay].
    Ogata N.
    Rinsho Byori; 2009 Oct; 57(10):954-60. PubMed ID: 19928491
    [Abstract] [Full Text] [Related]

  • 4. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 5. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN.
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [Abstract] [Full Text] [Related]

  • 6. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 7. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 8. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY.
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [Abstract] [Full Text] [Related]

  • 9. The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
    Kafatos G, Anastassopoulou C, Nardone A, Andrews N, Barbara C, Boot HJ, Butur D, Davidkin I, Gelb D, Griskevicius A, Hesketh L, Icardi G, Jones L, Kra-Oz Z, Miller E, Mossong J, Nemecek V, de Ory F, Sobotová Z, Thierfelder W, Van Damme P, Hatzakis A.
    J Viral Hepat; 2007 Apr; 14(4):260-8. PubMed ID: 17381718
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY.
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [Abstract] [Full Text] [Related]

  • 11. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N, Kusano O, Sugamata Y, Itoh T, Mizuii M, Tanaka J, Yoshizawa H.
    Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
    [Abstract] [Full Text] [Related]

  • 12. Performance of the DiaSorin LIAISON(®) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay.
    Kinn S, Akhavan S, Agut H, Thibault V.
    J Clin Virol; 2011 Apr; 50(4):297-302. PubMed ID: 21330194
    [Abstract] [Full Text] [Related]

  • 13. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M.
    Clin Infect Dis; 2007 May 01; 44(9):1161-9. PubMed ID: 17407033
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers.
    Kim H, Oh EJ, Kang MS, Kim SH, Park YJ.
    Ann Clin Lab Sci; 2007 May 01; 37(3):256-9. PubMed ID: 17709690
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS, Sawant P, Shirhatti RG, Vyas K, Vispute S, Dhadphale S, Patrawalla V, Desai N.
    Trop Gastroenterol; 2002 May 01; 23(3):120-1. PubMed ID: 12693152
    [Abstract] [Full Text] [Related]

  • 16. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov 01; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 17. [Comparative Study for Anti-Hepatitis B Surface Antigen Titers Based on Two Measurement Methods: Using Monoclonal Antibodies Isolated from Hepatitis B Vaccinated Recipients].
    Oone K, Kani S, Oohashi M, Shinkai N, Inoue T, Wakimoto Y, Tanaka Y.
    Rinsho Byori; 2015 Aug 01; 63(8):907-12. PubMed ID: 26638425
    [Abstract] [Full Text] [Related]

  • 18. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T, Okada Y, Umemori K, Mizusawa S, Sato S, Yamaguchi K.
    Jpn J Infect Dis; 2005 Apr 01; 58(2):83-7. PubMed ID: 15858285
    [Abstract] [Full Text] [Related]

  • 19. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
    Ogata N, Cote PJ, Zanetti AR, Miller RH, Shapiro M, Gerin J, Purcell RH.
    Hepatology; 1999 Sep 01; 30(3):779-86. PubMed ID: 10462386
    [Abstract] [Full Text] [Related]

  • 20. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
    Tuaillon E, Tabaa YA, Petitjean G, Huguet MF, Pajeaux G, Fondere JM, Ponseille B, Ducos J, Blanc P, Vendrell JP.
    J Immunol Methods; 2006 Aug 31; 315(1-2):144-52. PubMed ID: 16959261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.